Arax Advisory Partners
KMTS icon

Arax Advisory Partners’s Kestra Medical Technologies KMTS Stock Holding History

Arax Advisory Partners’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Buy
707
+669
+1,761% +$14K ﹤0.01% 4025
2026
Q1 		$100 Buy
+38
New +$896 ﹤0.01% 3614
2025
Q4 		– Sell
-117
Closed -$2.78K – 4628
2025
Q3 		$2.78K Buy
+117
New +$2.09K ﹤0.01% 3030

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Arax Advisory Partners's KMTS Position: Q2 2026 in Review

Arax Advisory Partners increased its Kestra Medical Technologies (KMTS) stake by 1,761% in Q2 2026, buying an estimated $14K and bringing the position to 707 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #4025.

Arax Advisory Partners first reported a position in KMTS in Q3 2025 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Arax Advisory Partners held 707 shares of Kestra Medical Technologies worth $18K as of Q2 2026.
  • Arax Advisory Partners bought 669 Kestra Medical Technologies shares in Q2 2026, an estimated $14K.
  • Kestra Medical Technologies made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4025 holding.
  • Arax Advisory Partners first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 3 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.